ACHL
Price
$1.05
Change
-$0.02 (-1.87%)
Updated
Nov 15, 03:08 PM (EDT)
109 days until earnings call
JBPHF
Price
$0.29
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
Ad is loading...

ACHL vs JBPHF

Header iconACHL vs JBPHF Comparison
Open Charts ACHL vs JBPHFBanner chart's image
Achilles Therapeutics
Price$1.05
Change-$0.02 (-1.87%)
Volume$1.1K
CapitalizationN/A
Jacobio Pharmaceuticals Group
Price$0.29
Change-$0.00 (-0.00%)
Volume$5K
CapitalizationN/A
ACHL vs JBPHF Comparison Chart
Loading...
ACHL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ACHL vs. JBPHF commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHL is a Hold and JBPHF is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (ACHL: $1.07 vs. JBPHF: $0.29)
Brand notoriety: ACHL and JBPHF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHL: 111% vs. JBPHF: 100%
Market capitalization -- ACHL: $45.69M vs. JBPHF: $175.44M
ACHL [@Biotechnology] is valued at $45.69M. JBPHF’s [@Biotechnology] market capitalization is $175.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHL’s FA Score shows that 2 FA rating(s) are green whileJBPHF’s FA Score has 1 green FA rating(s).

  • ACHL’s FA Score: 2 green, 3 red.
  • JBPHF’s FA Score: 1 green, 4 red.
According to our system of comparison, ACHL is a better buy in the long-term than JBPHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHL’s TA Score shows that 3 TA indicator(s) are bullish.

  • ACHL’s TA Score: 3 bullish, 5 bearish.

Price Growth

ACHL (@Biotechnology) experienced а +2.39% price change this week, while JBPHF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.92%. For the same industry, the average monthly price growth was -3.17%, and the average quarterly price growth was +1.57%.

Reported Earning Dates

ACHL is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-5.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JBPHF($175M) has a higher market cap than ACHL($45.7M). ACHL YTD gains are higher at: 20.360 vs. JBPHF (-19.089).
ACHLJBPHFACHL / JBPHF
Capitalization45.7M175M26%
EBITDAN/AN/A-
Gain YTD20.360-19.089-107%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
ACHL
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Ad is loading...
ACHL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

ACHL and

Correlation & Price change

A.I.dvisor tells us that ACHL and EWTX have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACHL and EWTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHL
1D Price
Change %
ACHL100%
+4.90%
EWTX - ACHL
33%
Poorly correlated
-1.17%
VKTX - ACHL
30%
Poorly correlated
-2.71%
VTYX - ACHL
28%
Poorly correlated
-2.48%
CRNX - ACHL
26%
Poorly correlated
+1.26%
JBPHF - ACHL
25%
Poorly correlated
N/A
More

JBPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, JBPHF has been loosely correlated with DTIL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if JBPHF jumps, then DTIL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JBPHF
1D Price
Change %
JBPHF100%
N/A
DTIL - JBPHF
47%
Loosely correlated
-4.70%
LVTX - JBPHF
38%
Loosely correlated
-2.35%
BIVI - JBPHF
31%
Poorly correlated
-6.74%
MIST - JBPHF
31%
Poorly correlated
-1.63%
HUMA - JBPHF
30%
Poorly correlated
-9.36%
More